This inventor holds 2 USPTO granted patents. Top assignee: K.v. Pharmaceutical Company. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2008
Title: Michael N Grimshaw: Innovator in Pharmaceutical Technology
Introduction
Michael N Grimshaw is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of rapidly disintegrating tablets. With a total of two patents to his name, Grimshaw's work has the potential to enhance the efficiency of drug delivery systems.
Latest Patents
Grimshaw's latest patents focus on the formulation and production of rapidly disintegrating tablets. The invention provides a rapidly disintegrating tablet that comprises an active ingredient, a water-soluble, directly compressible carbohydrate, and a water-soluble, directly compressible filler. Additionally, the method of producing these tablets involves wet granulating a mixture that includes a directly compressible, water-soluble carbohydrate, a directly compressible, water-insoluble filler, a beneficial ingredient, and a solvent. This innovative approach aims to improve the speed and effectiveness of medication administration.
Career Highlights
Throughout his career, Grimshaw has been associated with K.V. Pharmaceutical Company, where he has played a crucial role in advancing pharmaceutical formulations. His expertise in creating effective drug delivery systems has positioned him as a valuable asset in the industry.
Collaborations
Grimshaw has collaborated with notable colleagues, including Donald J Barbieri and Louise M Vizzini. These partnerships have contributed to the development of innovative solutions in the pharmaceutical sector.
Conclusion
Michael N Grimshaw's contributions to the field of pharmaceutical technology, particularly through his patents on rapidly disintegrating tablets, highlight his role as an influential inventor. His work continues to pave the way for advancements in drug delivery systems, benefiting both the industry and patients alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile